176 related articles for article (PubMed ID: 15008862)
1. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.
Kern P; Ramelet AA; Wutschert R; Bounameaux H; Hayoz D
Dermatol Surg; 2004 Mar; 30(3):367-72; discussion 372. PubMed ID: 15008862
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins.
Kern P; Ramelet AA; Wutschert R; Mazzolai L
Dermatol Surg; 2011 Nov; 37(11):1590-4. PubMed ID: 21883648
[TBL] [Abstract][Full Text] [Related]
3. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
McCoy S; Evans A; Spurrier N
Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
[TBL] [Abstract][Full Text] [Related]
5. Postsclerotherapy hyperpigmentations. Chromated glycerin as a screen for patients at risk (a retrospective study).
Georgiev M
J Dermatol Surg Oncol; 1993 Jul; 19(7):649-52. PubMed ID: 8349903
[TBL] [Abstract][Full Text] [Related]
6. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol.
Goldman MP
Dermatol Surg; 2002 Jan; 28(1):52-5. PubMed ID: 11991271
[TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
8. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
Rao J; Wildemore JK; Goldman MP
Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
[TBL] [Abstract][Full Text] [Related]
9. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
[TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
[TBL] [Abstract][Full Text] [Related]
11. Polidocanol or chromated glycerin for sclerotherapy of telangiectatic leg veins? With reply from Dr Kern et al.
Noël B
Dermatol Surg; 2004 Sep; 30(9):1272; author reply 1272-3. PubMed ID: 15355378
[No Abstract] [Full Text] [Related]
12. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol.
Weiss RA; Weiss MA
J Dermatol Surg Oncol; 1990 Sep; 16(9):800-4. PubMed ID: 2398199
[TBL] [Abstract][Full Text] [Related]
13. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol.
Norris MJ; Carlin MC; Ratz JL
J Am Acad Dermatol; 1989 Apr; 20(4):643-9. PubMed ID: 2654207
[TBL] [Abstract][Full Text] [Related]
14. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns.
Fonseca MM; Mocelin FJ; Grill MH; Gianesini S; Miyake K; Argenta R; Pereira AH
Phlebology; 2023 Apr; 38(3):165-171. PubMed ID: 36657386
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.
Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999
[TBL] [Abstract][Full Text] [Related]
16. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T).
Bertanha M; Yoshida WB; Bueno de Camargo PA; Moura R; Reis de Paula D; Padovani CR; Sobreira ML
Eur J Vasc Endovasc Surg; 2021 Jan; 61(1):128-135. PubMed ID: 32778489
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.
Hoss E; Kollipara R; Boen M; Alhaddad M; Goldman MP
Dermatol Surg; 2020 Dec; 46(12):1715-1720. PubMed ID: 32947299
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
19. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.
Bertanha M; Jaldin RG; Moura R; Pimenta REF; Mariúba JVO; Lúcio Filho CEP; Alcantara GP; Padovani CR; Yoshida WB; Sobreira ML
JAMA Dermatol; 2017 Dec; 153(12):1249-1255. PubMed ID: 28973414
[TBL] [Abstract][Full Text] [Related]
20. Sclerotherapy for lower limb telangiectasias.
Schwartz L; Maxwell H
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008826. PubMed ID: 22161437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
